Company news
Irlab Therapeutics Ab Class A (OMXSTO:IRLAB_A) news
Irlab Therapeutics Ab Class A news releases on 6ix. Latest, Sep 24, 2026: IRLAB Appoints Janne Backman as New Chairman of the Board
Press releases & updates
IRLAB Appoints Janne Backman as New Chairman of the Board
September 24, 2026
Report from the Extraordinary General Meeting of IRLAB Therapeutics AB
June 5, 2026
IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process (ISP)
January 19, 2026
IRLAB Receives Approval for a Phase Ib Study with IRL757 in Parkinson's Disease
December 23, 2025
The European Patent Office Intends to Grant a New Patent for IRLAB's Mesdopetam
December 11, 2025
IRLAB Appoints Gustaf Albèrt as the New Chief Financial Officer
October 9, 2025
IRLAB Progresses Fully Funded IRL757 Study in Parkinson's Disease in Partnership with MSRD
October 2, 2025
IRLAB Is Granted a Patent Strengthening the Market Exclusivity of The Drug Candidate Mesdopetam in China
September 4, 2025
IRLAB Appoints Roy Jonebrant as Interim CFO
August 21, 2025
IRLAB Reports Positive Results from the Second Part of a Phase I Study with IRL757
May 28, 2025
IRLAB is Granted a Patent Expanding the Patent Protection for the Drug Candidate Mesdopetam in the US
May 13, 2025